# A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

> **NCT02057484** · — · COMPLETED · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 2300 (actual)

## Conditions studied

- Liver Transplant
- Kidney Transplant

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT02057484
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-03
- **Primary completion:** 2017-10-17
- **Final completion:** 2017-10-17
- **Target enrollment:** 2300 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057484, "A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02057484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*